Encapsulation and characterization of flurbiprofen loaded poly(є-caprolactone)–poly(vinylpyrrolidone) blend micropheres by solvent evaporation method
Source abstract
Abstract
Flurbiprofen loaded PCL/PVP blend microspheres were prepared by o/w solvent evaporation method using various concentrations of gelatin as emulsifying agent. Microsphere recovery decreased with a decrease in the concentration of the emulsifier in the dispersion. Encapsulation efficiency and drug loading of microspheres increased with decrease in concentration of emulsifying agent. Hydration rate, encapsulation efficiency and drug loading of microspheres increased with increase in concentration of PVP. Rheological properties showed free flowing nature of microspheres. SEM (Scanning electron microscope) revealed microspheres were discrete, spherical and became porous with decrease in concentration of emulsifying agent but smooth with higher concentration of emulsifying agent. FTIR (Fourier transform infrared spectroscopy) spectra of pure and encapsulated flurbiprofen in all formulation showed no significant difference in characteristic peaks, suggesting stability of flurbiprofen during encapsulation process. X-RD (X-ray powder diffractometry) of pure flurbiprofen shows sharp peaks, which decreases on encapsulation, indicating dispersion at molecular level and hence decrease in the crystallinity of drug in microspheres. Microspheres showed an enteric nature at pH 1.2 and a sustained release pattern at pH 6.8. Rapid drug release was observed in microspheres with higher concentration of PVP (polyvinylpyrrolidone), PVP acts as channeling agent. Formulation with low concentration of emulsifying agent also showed a fast release due to porous structure. Drug release kinetics followed zero order at pH 1.2 while at pH 6.8 Higuchi model was best fitted and was found non fickian.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Nokhodchi A, Farid D (2002) Pharm Technol 26:54–6010.2118/0202-0060-JPT ↗
2. Bi-Botti C, Youan, Hussain A, Nguyen NT (2003) AAPS PharmSci 5(2):123–131, Article 2210.1208/ps050222 ↗
3. Mathew ST, Devi SG, Sandhya KV (2007) AAPS PharmSci 8(1):14
4. Ohmukai O (1996) Adv Drug Deliv Rev 20:203–20710.1016/0169-409X(95)00123-O ↗
5. Fang JY, Leu YL, Chang CC, Lin CH, Tsai YH (2004) Drug Deliv 11:97–105. doi: 10.1080/1071754049028069710.1080/10717540490280697 ↗
6. Kim BK, Hwang SJ, Park JB, Park HJ (2005) J Microencapsul 22:193–203. doi: 10.1080/0265204040001534610.1080/02652040400015346 ↗
7. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Int J Pharm 278:1–23. doi: 10.1016/j.ijpharm.2004.01.04410.1016/j.ijpharm.2004.01.044 ↗
8. Emeje MO, Kunle OO, Ofoefule SI (2006) AAPS PharmSciTech 7:E1–E4. doi: 10.1208/pt07035810.1208/pt070358 ↗
9. Samati Y, Yuksel N, Tarimci N (2006) Drug Deliv 13:105–111. doi: 10.1080/1071754050031333110.1080/10717540500313331 ↗
10. Sah H (1997) J Control Rel 47:233–245. doi: 10.1016/S0168-3659(97)01647-710.1016/S0168-3659(97)01647-7 ↗
11. Wang S, Guo S, Cheng L (2008) Int J Pharm 350:130–137. doi: 10.1016/j.ijpharm.2007.08.03010.1016/j.ijpharm.2007.08.030 ↗
12. Banker GS, Anderson NR (1987) Tablets. In: Lachmann L, Liberman HA, Kanig JL (eds) Theory and practice of industrial pharmacy. Lea and Febiger, Philadelphia, p 316
13. Shariff A, Manna PK, Paranjothy KLK, Manjula M (2007) Pak J Pharm Sci 20:1–9
14. Najib N, Suleiman M (1985) Drug Dev Ind Pharm 11:2169–2189. doi: 10.3109/0363904850908777910.3109/03639048509087779 ↗
15. Desai SJ, Singh P, Simonelli AP, Higuchi WI (1966) J Pharm Sci 55:1230–1234. doi: 10.1002/jps.260055111310.1002/jps.2600551113 ↗
16. Higuchi T (1963) Pharm Sci 50:1145–114910.1002/jps.2600521210 ↗
17. Hixon AW, Crowel JH (1931) Ind Eng Chem 23:923–931. doi: 10.1021/ie50260a01810.1021/ie50260a018 ↗
18. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Int J Pharm 15:25–35. doi: 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
19. Lai M-K, Tsiang RC-C (2004) J Microencapsul 21:307–316. doi: 10.1080/0265204041000167392810.1080/02652040410001673928 ↗
20. Rosilio V, Costa M, Baszkin A (1998) J Dispersion Sci Technol 19:821–841. doi: 10.1080/0193269980891321710.1080/01932699808913217 ↗
21. Sahoo SK, Mallick AA, Barik BB, Senapati PC (2005) Trop J Pharm Res 4:369–375
22. Paradkar A, Mahehwari M, Tyagi AK, Chauhan B, Kadam SS (2003) AAPS PharmSciTech 4:1–9. doi: 10.1208/pt04046510.1208/pt040465 ↗
23. Babu VR, Reddy KM, Sairam M, Subha MCS, Mallikarjuna NN, Kulkarni PV, Aminabhavi TM (2007) Des Monomers Polymers 10:155–165. doi: 10.1163/15685550778037827610.1163/156855507780378276 ↗
24. Jeong JC, Lee J, Cho K (2003) J Control Rel 92:249–258. doi: 10.1016/S0168-3659(03)00367-510.1016/S0168-3659(03)00367-5 ↗
25. Assimopoulou AN, Papageorgiou VP (2004) J Microencapsul 21:161–173. doi: 10.1080/0265204031000163783910.1080/02652040310001637839 ↗